$303 Million is the total value of Affinity Asset Advisors, LLC's 74 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 61.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $22,594,886 | +5.4% | 976,021 | +19.3% | 7.46% | -11.3% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $22,530,180 | +10.9% | 93,000 | +32.9% | 7.44% | -6.7% |
| SPY | New | SPDR S&P 500 ETF TRTR UNITcall | $18,422,550 | – | 45,000 | +100.0% | 6.08% | – |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $16,098,000 | +95.1% | 150,000 | +100.0% | 5.31% | +64.2% |
| MRK | New | MERCK & CO INC | $12,766,800 | – | 120,000 | +100.0% | 4.21% | – |
| VKTX | Buy | VIKING THERAPEUTICS INC | $10,360,446 | +214.9% | 622,249 | +77.8% | 3.42% | +165.0% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $9,444,789 | +31.7% | 1,083,118 | -5.3% | 3.12% | +10.8% |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $9,268,200 | +36.7% | 380,000 | +76.7% | 3.06% | +15.0% |
| VRNA | Buy | VERONA PHARMA PLCsponsored adr | $9,092,646 | +11.4% | 452,821 | +44.9% | 3.00% | -6.3% |
| Buy | VENTYX BIOSCIENCES INC | $8,710,268 | +10.4% | 260,008 | +8.1% | 2.88% | -7.1% | |
| CYTK | Buy | CYTOKINETICS INC | $7,793,283 | +94.2% | 221,463 | +152.8% | 2.57% | +63.4% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $7,669,794 | -38.8% | 113,224 | -40.6% | 2.53% | -48.5% |
| Buy | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $7,410,000 | +117.3% | 10,000,000 | +33.3% | 2.44% | +82.9% | |
| Buy | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $7,120,872 | +82.8% | 11,000,000 | +10.0% | 2.35% | +53.8% | |
| Buy | ASTRIA THERAPEUTICS INC | $7,040,608 | +0.1% | 529,369 | +12.0% | 2.32% | -15.8% | |
| BBIO | New | BRIDGEBIO PHARMA INCput | $6,462,884 | – | 389,800 | +100.0% | 2.13% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $6,345,569 | +34.6% | 881,329 | +53.6% | 2.09% | +13.3% |
| Sell | ARCELLX INC | $6,249,316 | -16.0% | 202,834 | -15.5% | 2.06% | -29.3% | |
| MRNA | New | MODERNA INCcall | $5,375,300 | – | 35,000 | +100.0% | 1.77% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $5,305,600 | – | 320,000 | +100.0% | 1.75% | – |
| MORF | Sell | MORPHIC HLDG INC | $5,113,883 | -31.9% | 135,863 | -51.6% | 1.69% | -42.7% |
| KURA | Buy | KURA ONCOLOGY INC | $4,369,620 | +31.0% | 357,287 | +32.9% | 1.44% | +10.2% |
| INZY | Buy | INOZYME PHARMA INC | $4,307,791 | +720.5% | 751,796 | +50.4% | 1.42% | +590.3% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $4,288,800 | -50.5% | 40,000 | -43.7% | 1.42% | -58.4% |
| AZN | ASTRAZENECA PLCsponsored adr | $4,164,600 | +2.4% | 60,000 | 0.0% | 1.37% | -13.9% | |
| SGEN | Buy | SEAGEN INC | $4,049,400 | +530.2% | 20,000 | +300.0% | 1.34% | +430.2% |
| ARGX | Buy | ARGENX SEsponsored adr | $4,005,235 | +111.5% | 10,750 | +115.0% | 1.32% | +77.9% |
| AZN | New | ASTRAZENECA PLCcall | $3,470,500 | – | 50,000 | +100.0% | 1.14% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $3,221,100 | +63.4% | 90,000 | +80.0% | 1.06% | +37.5% |
| ETNB | New | 89BIO INC | $3,046,000 | – | 200,000 | +100.0% | 1.00% | – |
| Buy | ESPERION THERAPEUTICS INC NEnote 4.000%11/1 | $3,008,250 | +120.6% | 7,500,000 | +200.0% | 0.99% | +85.6% | |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored adr | $2,633,889 | +84.6% | 684,127 | +48.6% | 0.87% | +55.2% |
| VRDN | New | VIRIDIAN THERAPEUTICS INCcall | $2,556,720 | – | 100,500 | +100.0% | 0.84% | – |
| LNTH | Sell | LANTHEUS HLDGS INC | $2,496,945 | -19.2% | 30,244 | -50.1% | 0.82% | -32.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $2,431,000 | -70.6% | 25,000 | -68.8% | 0.80% | -75.3% |
| NVAX | Buy | NOVAVAX INCput | $2,403,324 | +16.9% | 346,800 | +73.4% | 0.79% | -1.6% |
| PCVX | Buy | VAXCYTE INC | $2,332,118 | -18.9% | 62,223 | +3.7% | 0.77% | -31.7% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $2,308,600 | – | 35,000 | +100.0% | 0.76% | – |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $2,281,900 | +192.6% | 95,000 | +137.5% | 0.75% | +146.1% |
| KRTX | New | KARUNA THERAPEUTICS INC | $2,270,500 | – | 12,500 | +100.0% | 0.75% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $2,182,800 | -57.4% | 20,000 | -55.6% | 0.72% | -64.1% |
| ALPN | ALPINE IMMUNE SCIENCES INC | $1,913,719 | +5.0% | 247,891 | 0.0% | 0.63% | -11.6% | |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $1,799,000 | -63.3% | 50,000 | -54.5% | 0.59% | -69.1% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,793,208 | -20.2% | 460,979 | -30.3% | 0.59% | -32.9% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $1,637,175 | +28.6% | 208,292 | +10.6% | 0.54% | +8.2% |
| VKTX | New | VIKING THERAPEUTICS INCput | $1,563,435 | – | 93,900 | +100.0% | 0.52% | – |
| VINC | VINCERX PHARMA INC | $1,552,482 | +2.0% | 1,492,771 | 0.0% | 0.51% | -14.2% | |
| COGT | Sell | COGENT BIOSCIENCES INC | $1,543,661 | -30.8% | 143,064 | -25.9% | 0.51% | -41.8% |
| PRECIGEN INCnote 3.500% 7/0 | $1,465,511 | -1.5% | 1,500,000 | 0.0% | 0.48% | -17.1% | ||
| NRIX | Buy | NURIX THERAPEUTICS INC | $1,332,000 | +51.6% | 150,000 | +87.5% | 0.44% | +27.9% |
| LIANBIOsponsored adr | $1,267,500 | +18.9% | 650,000 | 0.0% | 0.42% | 0.0% | ||
| NARI | Sell | INARI MED INC | $1,234,800 | -78.4% | 20,000 | -77.8% | 0.41% | -81.8% |
| ADCT | New | ADC THERAPEUTICS SA | $1,170,000 | – | 600,000 | +100.0% | 0.39% | – |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $1,087,490 | -50.8% | 149,586 | -50.7% | 0.36% | -58.6% |
| ACRS | New | ACLARIS THERAPEUTICS INCcall | $1,044,419 | – | 129,100 | +100.0% | 0.34% | – |
| New | MINERALYS THERAPEUTICS INC | $978,750 | – | 62,500 | +100.0% | 0.32% | – | |
| New | THESEUS PHARMACEUTICALS INC | $872,202 | – | 98,221 | +100.0% | 0.29% | – | |
| BCAB | Buy | BIOATLA INC | $871,000 | -29.6% | 325,000 | +116.7% | 0.29% | -40.8% |
| New | JASPER THERAPEUTICS INC | $863,276 | – | 476,948 | +100.0% | 0.28% | – | |
| FHTX | Buy | FOGHORN THERAPEUTICS INC | $847,980 | +20.8% | 136,771 | +24.3% | 0.28% | +1.8% |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $785,565 | +98.4% | 199,382 | +99.4% | 0.26% | +67.1% |
| New | ROIVANT SCIENCES LTD | $738,000 | – | 100,000 | +100.0% | 0.24% | – | |
| ESPR | New | ESPERION THERAPEUTICS INC NEput | $556,500 | – | 350,000 | +100.0% | 0.18% | – |
| ETNB | New | 89BIO INCcall | $551,326 | – | 36,200 | +100.0% | 0.18% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $548,008 | – | 177,349 | +100.0% | 0.18% | – |
| NLSP | New | NLS PHARMACEUTICS LTD | $519,574 | – | 344,089 | +100.0% | 0.17% | – |
| NUVB | NUVATION BIO INC | $415,000 | -13.5% | 250,000 | 0.0% | 0.14% | -27.1% | |
| GLYC | New | GLYCOMIMETICS INCput | $378,000 | – | 300,000 | +100.0% | 0.12% | – |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $299,583 | – | 306,950 | +100.0% | 0.10% | – |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $269,574 | -42.6% | 187,204 | 0.0% | 0.09% | -51.6% | |
| New | NEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202 | $68,450 | – | 37,000 | +100.0% | 0.02% | – | |
| SCILEX HOLDING CO*w exp 11/10/202 | $19,004 | +455.8% | 18,099 | 0.0% | 0.01% | +500.0% | ||
| New | ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $12,255 | – | 75,000 | +100.0% | 0.00% | – | |
| SCILEX HOLDING CO | $3,797 | +105.6% | 463 | 0.0% | 0.00% | 0.0% | ||
| MSACW | Exit | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $0 | – | -33,333 | -100.0% | -0.00% | – |
| Exit | CONTEXT THERAPEUTICS INC | $0 | – | -883,654 | -100.0% | -0.23% | – | |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -92,170 | -100.0% | -0.42% | – |
| NVCR | Exit | NOVOCURE LTDcall | $0 | – | -25,000 | -100.0% | -0.72% | – |
| GERN | Exit | GERON CORPcall | $0 | – | -837,000 | -100.0% | -0.79% | – |
| VKTX | Exit | VIKING THERAPEUTICS INCcall | $0 | – | -250,000 | -100.0% | -0.92% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -375,000 | -100.0% | -0.94% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -1.00% | – |
| GERN | Exit | GERON CORPput | $0 | – | -1,056,500 | -100.0% | -1.00% | – |
| VRNA | Exit | VERONA PHARMA PLCcall | $0 | – | -105,000 | -100.0% | -1.08% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -258,115 | -100.0% | -1.98% | – |
| AMGN | Exit | AMGEN INCput | $0 | – | -20,000 | -100.0% | -2.06% | – |
| MRNA | Exit | MODERNA INCput | $0 | – | -30,000 | -100.0% | -2.11% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB COput | $0 | – | -175,000 | -100.0% | -4.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-13 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.